Exact Mass: 358.2005
Exact Mass Matches: 358.2005
Found 500 metabolites which its exact mass value is equals to given mass value 358.2005
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
2-(3,7,11-Trimethyldodeca-2,6,10-trienylsulfanyl)benzoic acid
4,4'-Thiobis(6-tert-butyl-m-cresol)
Itopride
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03F - Propulsives > A03FA - Propulsives C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor
Itopride
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03F - Propulsives > A03FA - Propulsives C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor
12-oxoisospongia-13,15-dien-20-yl acetate|20-acetoxymarginatone
(3S,4aS,10aS)-1,2,3,4,4a,9,10,10a-octahydro-6-hydroxy-7-isopropyl-1,1,4a-trimethyl-9-oxophenanthren-3-yl acetate|2alpha-acetoxysugiol
2-(4-Methoxy-3-methyl-6-isopropylphenoxy)-4-methoxy-3-methyl-6-isopropylphenol
1-[7,8-dihydro-7-hydroxy-7-methyl-8-oxo-3-(1E)-1-propenyl-6H-2-benzopyran]undecan-2-one|rubropunctin
12-acetylroyleanone|12-O-Acetoxy-royleanon|7-acetyl-royleanone|Royleanone Acetat
3-acetoxyhelioscopinolide B|3beta-Acetoxy-Helioscopinolide B
(-)-(1betaH,7E)-6-beta-acetoxyverticilla-4(18),7,11-triene-10,12-gamma-lactone|(5R,10S,11E,13aR)-2,4,5,6,7,8,9,10,13,13a-decahydro-4,4,12-trimethyl-8-methylidene-2-oxo-3,5-ethanocyclododeca[b]furan-10-yl acetate|cespihypotin Y
(+)-hyatellaquinone|3-[[(1R,4aR,8aR)-decahydro-5,5,8a-trimethyl-2-methylene-1-naphthalenyl]methyl]-2-hydroxy-5-methoxy-2,5-cyclohexadiene-1,4-dione|3-{[(1R,4aR,5R,8aR)-decahydro-5,5,8a-trimethyl-2-methylenenaphthalen-1-yl]methyl}-2-hydroxy-5-methoxycyclohexa-2,5-diene-1,4-dione|hyatellaquinone
19-acetoxy-15,16-epoxy-8(17),13(16),14-ent-labdatrien-20-al
2,3-epoxy-jaeschkeanadiol benzoate|epoxybenz|epoxyferutinol benzoate|epoxyjaeschkeanadiol benzoate
(2S,3S)-6-carboxy-2,3-dihydro-3-hydroxy-2-methyl-2-(4-methylpenta-3-enyl)-8-(3-methyl-2-butenyl)chroman|myrsinoic acid C
5-O-acetyl-13-deacetoxy-guanacastepene A|heptemerone G
2-[2-(5-hydroxy-2,7-dimethyl-2H-chromen-2-yl)-ethyl]-3,3-dimethyl-cyclohexanecarboxylic acid|Siccanochromen-G|Siccanochromene-G
12-formyl-11-hydroxy-8,11,13-abietatrien-2-oic acid methylester
(1S*,2S*,11S*,3E,7E,12Z)-11-acetoxycembra-3,7,12(13),15(17)-tetraen-16,2-olide|crassocolide P
4beta,9alpha-dihydroxy-6alpha-benzoyl-dauc-7-ene|lancerotriol benzoate
(2R,13Z)-2-acetoxy-10-oxo-4,10-secospata-2,13(15),17-trien-12-al
4-hydroxy-3-((E)-4-hydroxy-3,7-dimethyl-octa-2,6-dienyl)-5-(3-methyl-but-2-enyl)-benzoic acid
5-Acetyl-2,3-dihydrobenzofuran 2-(2-methyleneethanol)nonanoate
4beta,8beta-dihydroxy-6alpha-benzoyldauc-9-ene|feruhermonin B
5-hydroxy-2,6,8-trimethyl-8-(3,7-dimethyl-2,6-octadienyl)-2H-1-benzopyran-4,7(3H,8H)-dione
12beta-Hydroxy-16alpha-methoxy-pregna-4,6-dien-3,20-dion
Ac-(5alpha,10alpha,11beta,13alpha)-5,10-Epoxy-11-hydroxy-1,15-rosadien-3-one
Di-Me ester-8,11,13-Cleistanthatriene-17,19-dioic acid
(5R,13Z)-5-acetoxy-10-oxo-4,10-secospata-2,13(15),17-trien-12-al|(5R,13Z)-5.acetoxy-10-oxo-4,10-secospata-2,13(15),17-trien-12-al
2-hydroxy-4-methoxy-3-{[(2S,4aS,8aS)-octahydro-2,5,5,8a-tetramethylnaphthalen-1(2H)-ylidene]methyl}cyclohexa-2,5-diene-1,4-dione|Spongiachinon|Spongiaquinone
irciformonin A|rel-(2R,2S,5S)-5-[(1E,4E)-7-(furan-3-yl)-4-methylhepta-1,4-dien-1-yl]hexahydro-2,5-dimethyl-[2,2-bifuran]-5(2H)-one
ent-(5beta,8alpha,9beta,10alpha,11alpha,12alpha)-3,14-dioxoatis-16-en-11-yl acetate
(-)-(4S,5S,10R,20R)-12,18-dihydroxy-7-oxo-abieta-8,11,13-trien-20-aldehyde 18,20-ethyl acetal
An abietane diterpenoid isolated from the stem bark of Fraxinus sieboldiana.
S-Farnesylthiosalicylic acid;Farnesyl Thiosalicylic Acid;FTS
yohimbinic acid
Yohimbic acid hydrate is an amphoteric demethylated derivative of Yohimbine (HY-12715). Yohimbic acid hydrate exhibits vasodilatory action. Yohimbic acid hydrate also can be used for the research of osteoarthritis (OA)[1][2][3].
Tefestrol
Ferutinine is a natural product found in Ferula jaeschkeana, Ferula sinaica, and other organisms with data available. Ferutinin, a natural terpenoid compound, is an estrogen receptor ERα agonist and estrogen ERβ-receptor agonist/antagonist with IC50s of 33.1 nM and 180.5 nM, respectively. Ferutinin acts as an electrogenic Ca2+-ionophore that increases calcium permeability of lipid bilayer membranes, mitochondria. Ferutinin possesses estrogenic, antitumor, antibacterial and antiinflammatory activities[1][2].
(3S,4aS,10aS)-3-(Acetyloxy)-2,3,4,4a,10,10a-hexahydro-6-hydroxy-1,1,4a-trimethyl-7-(1-methylethyl)-9(1H)-phenanthrenone
2alpha-Acetoxysugiol is a natural product found in Salvia miltiorrhiza with data available.
4-hydroxy-3-[(2E,6E)-4-hydroxy-3,7,11-trimethyldodeca-2,6,10-trienyl]benzoic acid
4-[4-(3,4-dimethoxyphenyl)-2,3-dimethylbutyl]-1,2-dimethoxybenzene
5-[10-(3,5-dihydroxyphenyl)decyl]benzene-1,3-diol
2-(2-hydroxy-6-methylhept-5-en-2-yl)-7-(3-methylbut-2-enyl)-2,3-dihydro-1-benzofuran-5-carboxylic acid
2-(2-hydroxy-6-methylhept-5-en-2-yl)-7-(3-methylbut-2-enyl)-2,3-dihydro-1-benzofuran-5-carboxylic acid
canrenoic acid
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D000451 - Mineralocorticoid Receptor Antagonists C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
4-[4-(3,4-dimethoxyphenyl)-2,3-dimethylbutyl]-1,2-dimethoxybenzene [IIN-based: Match]
4-hydroxy-3-[(2E,6E)-4-hydroxy-3,7,11-trimethyldodeca-2,6,10-trienyl]benzoic acid [IIN-based on: CCMSLIB00000847074]
2-(2-hydroxy-6-methylhept-5-en-2-yl)-7-(3-methylbut-2-enyl)-2,3-dihydro-1-benzofuran-5-carboxylic acid [IIN-based on: CCMSLIB00000848922]
2-(2-hydroxy-6-methylhept-5-en-2-yl)-7-(3-methylbut-2-enyl)-2,3-dihydro-1-benzofuran-5-carboxylic acid [IIN-based: Match]
4-hydroxy-3-[(2E,6E)-4-hydroxy-3,7,11-trimethyldodeca-2,6,10-trienyl]benzoic acid [IIN-based: Match]
4-hydroxy-3-[(2E,6E)-4-hydroxy-3,7,11-trimethyldodeca-2,6,10-trienyl]benzoic acid_major
cyclic 3,17-bis(1,2-ethanediyl acetal) estra-5(10),9(11)- diene-3,17-dione
Salirasib
D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1902 - Ras Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors Salirasib is a Ras inhibitor that inhibits specifically both oncogenically activated Ras and growth factor receptor-mediated Ras activation, resulting in the inhibition of Ras-dependent tumor growth.
tetramethyl Nordihydroguaiaretic Acid
Terameprocol is a synthetic derivative of Nordihydroguaiaretic acid and a non-selective lipoxygenase inhibitor. Terameprocol has antiviral and antitumor effects[1][2][3].
4S-hydroxy-8-oxo-(5E,9Z,13Z,16Z,19Z)-neuroprostapentaenoic acid-cyclo[7S,11S]
Sorgoleone
11,12-Dimethoxy-8,11,13-abietatrien-20,7-olide
FA 22:7;O2
Polycerasoidol
[5-(Cyclohexylamino)-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-1H-in dol-2-yl]boronic acid
TERT-BUTYL 5-METHYL-6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-BENZO[D]IMIDAZOLE-1-CARBOXYLATE
19-Norpregna-5(10),9(11)-diene-3,20-dione, 17-hydroxy-cyclic 3-(1,2-ethanediyl acetal)
4-(trans-4-Propylcyclohexyl)-2,3-difluoro-4-ethoxy-1,1-biphenyl
DI-TERT-BUTYL(2,6-DIMETHOXY-[1,1-BIPHENYL]-2-YL)PHOSPHINE
[1-[(2-methylpropan-2-yl)oxycarbonyl]-5-(piperidin-1-ylmethyl)indol-2-yl]boronic acid
Terameprocol
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor Terameprocol is a synthetic derivative of Nordihydroguaiaretic acid and a non-selective lipoxygenase inhibitor. Terameprocol has antiviral and antitumor effects[1][2][3].
2-Methyl-2-propanyl 2-benzyl-1,3-dioxo-2,8-diazaspiro[4.5]decane- 8-carboxylate
1-N-BOC-3-METHYLINDAZOLE-5-BORONIC ACID PINACOL ESTER
1-BOC-2-[(2-TRIFLUOROMETHYL-PHENYLAMINO)-METHYL]-PIPERIDINE
1-BOC-2-[(3-TRIFLUOROMETHYL-PHENYLAMINO)-METHYL]-PIPERIDINE
1-BOC-2-[(4-TRIFLUOROMETHYL-PHENYLAMINO)-METHYL]-PIPERIDINE
B-[3,5-Difluoro-4-(trans-4-propylcyclohexyl)[1,1-biphenyl]-4-yl]boronic acid
7,8,9,10,18,19,20,21-Octahydro-6H,17H-dibenzo[b,k][1,4,10,13,7,16]tetraoxadiazacyclooctadecine
1,9-Diazaspiro[5.5]undecane, 1-(phenylmethyl)-, 2,2,2-trifluoroacetate (1:1)
buta-1,3-diene,ethyl prop-2-enoate,methyl 2-methylprop-2-enoate,styrene
GESTONORONE ACETATE:17ALPHA-ACETOXY-19-NORPREGN-4-EN-3,20-DIONE
Cimetropium
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics
Cannabichromenic acid, (+)-
3-Methoxy-16-methylestra-1,3,5(10)-triene-16beta,17beta-diol 17-acetate
N2-[(Benzyloxy)carbonyl]-N1-[(3S)-1-cyanopyrrolidin-3-YL]-L-leucinamide
4-Hydroxy-3-(4-hydroxy-3,7,11-trimethyldodeca-2,6,10-trienyl)benzoic acid
xenovulene A
A sesquiterpenoid based on a humulene skeleton. It is isolated from Sarocladium strictum and has been shown to exhibit inhibitory activity against GABA receptor.
3-[3-[(1E,3E,5Z,8Z,10E,12R,14Z)-12-hydroxyheptadeca-1,3,5,8,10,14-hexaenyl]oxiran-2-yl]propanoic acid
3-[3-[(1E,3E,5Z,8Z,10E,12S,14Z)-12-hydroxyheptadeca-1,3,5,8,10,14-hexaenyl]oxiran-2-yl]propanoic acid
(Z)-6-[3-[(1E,3E,5Z,7E,9R,11Z)-9-hydroxytetradeca-1,3,5,7,11-pentaenyl]oxiran-2-yl]hex-4-enoic acid
(6aR)-1-hydroxy-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromene-2-carboxylic acid
Myrsinoic acid C
A member of the class of chromanes that is 3,4-dihydro-2H-chromene substituted by a carboxy group at position 6, a hydroxy group at position 3, a methyl and a 4-methylpent-3-en-1-yl group at position 2 and a prenyl group at position 8 (the 2S,3S stereoisomer). Isolated from in Myrsine seguinii, it exhibits anti-inflammatory activity.
N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)propyl]-[1,2,4]triazolo[4,3-a]quinoxalin-4-amine
4-[[4-(2-Methoxyanilino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]-1-butanol
(1R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium
5-[(3,4-dimethylphenoxy)methyl]-N-methyl-N-(4-oxanylmethyl)-3-isoxazolecarboxamide
Trichosetin(1-)
An organic anion resulting from the deprotonation of the enol moiety of trichosetin.
3-[[(1S,2R,4As,8aR)-1,2,4a-trimethyl-5-methylidene-3,4,6,7,8,8a-hexahydro-2H-naphthalen-1-yl]methyl]-2-hydroxy-5-methoxycyclohexa-2,5-diene-1,4-dione
(5S)-3-[(2E,6R,8E,10E,12E)-2,6-dimethyltetradeca-2,8,10,12-tetraenoyl]-5-(hydroxymethyl)pyrrolidine-2,4-dione
3-Hydroxy-9-oxo-9,10-seco-23,24-bisnorchola-1,3,5(10)-trien-22-oic acid
[4-[1-(1-Cyclopentyl-5-tetrazolyl)propyl]-1-piperazinyl]-(2-furanyl)methanone
19-hydroxy-2,3-dinor-6-oxoprostaglandin F1alpha
A prostanoid that is 2,3-dinor-6-oxo-prostaglandin F1alpha in which a hydrogen at position 19 is replaced by a hydroxy group.
9alpha-Hydroxy-3-oxo-23,24-bisnorchola-1,4-dien-22-oic acid
(1S,2S,3E,7E,11E,13S)-13-Acetoxycembra-3,7,11,15-tetraen-17,2-olide
Cyclic 3,17-bis(1,2-ethanediyl acetal) estra-5(10),9(11)-diene-3,17-dione
(1S,2S,6R,7R)-6-ethyl-1,6-dimethoxyspiro[10-oxa-5-azatricyclo[5.3.1.04,8]undecane-2,3-indole]-2-one
(2E,9E)-4-hydroxy-2,5,5,9-tetramethylcycloundeca-2,9-dien-1-yl 4-hydroxybenzoate
17-Hydroxy-3-oxo-17alpha-pregna-4,6-diene-21-carboxylic acid
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D000451 - Mineralocorticoid Receptor Antagonists D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics
(R)-laudanosine(1+)
An organic cation that is the conjugate acid of (R)-laudanosine, obtained by protonation of the tertiary amino group; major species at pH 7.3.
4S(5)-epoxy-17R-hydroxydocosahexaenoic acid
An epoxy fatty acid that is (6E,8E,10Z,13Z,15E,19Z)-docosa-6,8,10,13,15,19-hexaenoic acid which is carrying an epoxy group at position 4S and a hydroxy group at position 17R. It is a metabolite of docosahexaenoic acid that can be converted to a D-resolvin.
delta(9)-Tetrahydrocannabinolic acid
A diterpenoid that is 6a,7,8,10a-tetrahydro-6H-benzo[c]chromene substituted at position 1 by a hydroxy group, positions 6, 6 and 9 by methyl groups and at position 3 by a pentyl group. A biosynthetic precursor to Delta(9)-tetrahydrocannabinol, the principal psychoactive constituent of the cannabis plant.
7S,8S-epoxy-17R-hydroxydocosahexaenoic acid
A hydroxydocosahexaenoic acid that is (4Z,9E,11E,13Z,15E,19Z)-docosa-4,9,11,13,15,19-hexaenoic acid carrying an epoxy group at position 7S and a hydroxy group at position 17R. It is a metabolite of docosahexaenoic acid, and serves as a precursor to D-resolvins.
FTIDC
FTIDC is an orally active, noncompetitive, selective allosteric metabotropic glutamate receptor (mGluR) 1 antagonist with an IC50 of 5.8 nM for human mGluR1a. FTIDC has no species differences in its antagonistic activity on recombinant human, mouse, and rat mGluR1[1].
8-(3,7-dimethylocta-2,6-dien-1-yl)-5-hydroxy-2,6,8-trimethyl-2,3-dihydro-1-benzopyran-4,7-dione
2-[(1s,6s)-6-[(3r)-3-hydroxypent-1-en-2-yl]-1,3,5-trimethylcyclohexa-2,4-dien-1-yl]-6-methoxy-3,5-dimethylpyran-4-one
[(3ar,15as)-10,14-dimethyl-3-methylidene-2-oxo-3ah,4h,7h,8h,11h,12h,15h,15ah-cyclotetradeca[b]furan-6-yl]methyl acetate
{6,14-dimethyl-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,12h,13h,15ah-cyclotetradeca[b]furan-10-yl}methyl acetate
(2r,3r,4r)-4-dodecyl-3-hydroxy-5-oxooxolane-2,3-dicarboxylic acid
(2r,8s)-8-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-5-hydroxy-2,6,8-trimethyl-2,3-dihydro-1-benzopyran-4,7-dione
3-{[(1s,2r,4ar,8ar)-1,2,4a-trimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl]methyl}-2-hydroxy-5-methoxycyclohexa-2,5-diene-1,4-dione
(1s,2r,3as,5r,8r,11s)-2,5,11-trimethyl-4,10-dioxo-8-(prop-1-en-2-yl)-1h,2h,3h,3ah,5h,8h,9h,11h-cyclopenta[11]annulen-1-yl acetate
3,6,9-trimethyl-1-(2-methylprop-1-en-1-yl)-7,10-dioxo-1h,2h,3h,3ah,4h,5h,6h,6ah-cyclopenta[e]naphthalen-8-yl acetate
2-[(1s,2s)-1-carboxy-2-methylbutyl]-5-hydroxy-5,7,7-trimethyl-9-oxo-5ah,6h-cyclopenta[g]isoquinolin-2-ium
2-{[(1r,4ar,8ar)-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]methyl}-3-hydroxy-5-(hydroxymethyl)cyclohexa-2,5-diene-1,4-dione
(2s,3s,4bs,8as)-2-ethenyl-2,4b,8,8-tetramethyl-4,10-dioxo-3,5,6,7,8a,9-hexahydro-1h-phenanthren-3-yl acetate
4-[(2s,3s)-4-(3,4-dimethoxyphenyl)-2,3-dimethylbutyl]-1,2-dimethoxybenzene
4-{3a,6,6,9a-tetramethyl-2,7-dioxo-hexahydro-1h-cyclopenta[a]naphthalen-3-ylidene}pent-2-enoic acid
6,10,14-trimethyl-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,12h,13h,15ah-cyclotetradeca[b]furan-9-yl acetate
(2s)-2-[(2s)-2-hydroxy-6-methylhept-5-en-2-yl]-7-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzofuran-5-carboxylic acid
3-{[(1e,2s,8as)-2,5,5,8a-tetramethyl-hexahydro-2h-naphthalen-1-ylidene]methyl}-2,5,6-trihydroxybenzaldehyde
(1r,2s,3r)-3-[(1s,5r)-2-formyl-5-[(2z)-6-methylhepta-2,5-dien-2-yl]cyclopent-2-en-1-yl]-2-methyl-4-oxocyclopentyl acetate
7a,11-dihydroxy-9-(hydroxymethyl)-4,4,12b-trimethyl-1,2,3,4a,5,6,7,12-octahydrotetraphen-8-one
3-hydroxy-3-isopropyl-6,8a-dimethyl-1,2,3a,4,5,6-hexahydroazulen-4-yl 4-hydroxybenzoate
3-[(5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl)methyl]-2-hydroxy-5-methoxycyclohexa-2,5-diene-1,4-dione
(6e,10e)-12-(5-hydroxy-2-methoxy-3-methylphenyl)-6,10-dimethyldodeca-6,10-diene-2,8-dione
(3s,4as,10ar,11ar,11bs)-4,4,8,11b-tetramethyl-9-oxo-1h,2h,3h,4ah,5h,6h,10ah,11h,11ah-phenanthro[3,2-b]furan-3-yl acetate
(2e)-3-[(1s,3r,4r,7r,8r,11s)-3-[(2z)-4-hydroxybut-2-en-2-yl]-4,6,8,10,11-pentamethyl-2-oxatricyclo[5.3.1.0⁴,¹¹]undeca-5,9-dien-8-yl]prop-2-enoic acid
5,5,9-trimethyl-14-methylidene-11,15-dioxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-3-yl acetate
(1r,2r,3as,5r,8r,11r)-2,5,11-trimethyl-4,10-dioxo-8-(prop-1-en-2-yl)-1h,2h,3h,3ah,5h,8h,9h,11h-cyclopenta[11]annulen-1-yl acetate
(2e)-3-[(1r,3r,4r,7r,8r,11s)-3-[(2z)-but-2-en-2-yl]-10-(hydroxymethyl)-4,6,8,11-tetramethyl-2-oxatricyclo[5.3.1.0⁴,¹¹]undeca-5,9-dien-8-yl]prop-2-enoic acid
(1r,2s,3s,5r,10r)-5-ethenyl-2,5,11,11-tetramethyl-12-oxo-15-oxatetracyclo[8.4.1.0¹,¹⁰.0²,⁷]pentadec-13-en-3-yl acetate
7a-hydroxy-9-(hydroxymethyl)-4,4,12b-trimethyl-2,3,4a,5,6,7,11a,12-octahydro-1h-tetraphene-8,11-dione
(3r,3as,4s,8as)-3-hydroxy-3-isopropyl-6,8a-dimethyl-1,2,3a,4,5,8-hexahydroazulen-4-yl 4-hydroxybenzoate
2-hydroxy-5-methoxy-3-(pentadeca-8,11,14-trien-1-yl)cyclohexa-2,5-diene-1,4-dione
(5ar,7s,9as,9br)-1,7-dihydroxy-3a,3b,6,6,9a-pentamethyl-4h,5h,5ah,7h,8h,9h,9bh-cyclopenta[a]phenanthrene-2,3-dione
2-[6-(3-hydroxypent-1-en-2-yl)-1,3,5-trimethylcyclohexa-2,4-dien-1-yl]-6-methoxy-3,5-dimethylpyran-4-one
4-dodecyl-3-hydroxy-5-oxooxolane-2,3-dicarboxylic acid
2-[(5e)-2-hydroxy-6,10-dimethylundeca-5,9-dien-2-yl]-2,3-dihydro-1-benzofuran-5-carboxylic acid
6,10,14-trimethyl-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,12h,13h,15ah-cyclotetradeca[b]furan-12-yl acetate
2-{11-hydroxy-9a,11a-dimethyl-7-oxo-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}propanoic acid
(2s,6r)-2-{2-[(1r,3r)-1,3-dimethyl-2-methylidenecyclohexyl]ethyl}-6-methoxy-2-methyl-6,7-dihydrochromene-5,8-dione
(3r,5s,7s)-8-hydroxy-4,4,7-trimethyl-9-(2-methylbutanoyl)-3-(prop-1-en-2-yl)tricyclo[5.3.1.0¹,⁵]undec-8-ene-10,11-dione
(3r,5s,7r)-10-hydroxy-4,4,7-trimethyl-9-(2-methylbutanoyl)-3-(prop-1-en-2-yl)tricyclo[5.3.1.0¹,⁵]undec-9-ene-8,11-dione
(2s,4s,4as,8s,8as)-8-formyl-4-[2-(furan-3-yl)ethyl]-4a,8-dimethyl-3-methylidene-hexahydro-1h-naphthalen-2-yl acetate
(3ar,12r,15as)-6,10,14-trimethyl-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,12h,13h,15ah-cyclotetradeca[b]furan-12-yl acetate
3-{[(1e,2s,4as,8as)-2,5,5,8a-tetramethyl-hexahydro-2h-naphthalen-1-ylidene]methyl}-2-hydroxy-5-methoxycyclohexa-2,5-diene-1,4-dione
5,6-dihydroxy-2',5',5',8'a-tetramethyl-3',4',4'a,6',7',8'-hexahydro-2'h,3h-spiro[1-benzofuran-2,1'-naphthalene]-7-carbaldehyde
(1r,2r,3e,5s,8e)-5-hydroxy-2-isopropyl-5,9-dimethylcyclodeca-3,8-dien-1-yl 4-hydroxybenzoate
2-isopropyl-4b,8,8-trimethyl-1,4-dioxo-5,6,7,8a,9,10-hexahydrophenanthren-3-yl acetate
(3s,4r,5s,6s,7r)-4,5,6,7-tetrahydroxy-3-(1-hydroxydecyl)-4,5,6,7-tetrahydro-3h-2-benzofuran-1-one
19-acetoxy-15,16-epoxy-8(17),13(16),14-ent-labdatrien-20-al
{"Ingredient_id": "HBIN002163","Ingredient_name": "19-acetoxy-15,16-epoxy-8(17),13(16),14-ent-labdatrien-20-al","Alias": "NA","Ingredient_formula": "C22H30O4","Ingredient_Smile": "CC(=O)OCC1(CCCC2(C1CCC(=C)C2CCC3=COC=C3)C=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "187","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
20-hydroxydihydrorankinidine
{"Ingredient_id": "HBIN003409","Ingredient_name": "20-hydroxydihydrorankinidine","Alias": "NA","Ingredient_formula": "C20H26N2O4","Ingredient_Smile": "CCC1(CNC2CC3(C4CC1C2CO4)C5=CC=CC=C5N(C3=O)OC)O","Ingredient_weight": "358.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10009","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101606432","DrugBank_id": "NA"}
4-hydroxy-2,6,8-trimethyl-6-(3,7-dimethyl-2,6-octadienyl)-2h-1-benzopyran-5,7(3h,6h)-dione
{"Ingredient_id": "HBIN010437","Ingredient_name": "4-hydroxy-2,6,8-trimethyl-6-(3,7-dimethyl-2,6-octadienyl)-2h-1-benzopyran-5,7(3h,6h)-dione","Alias": "NA","Ingredient_formula": "C22H30O4","Ingredient_Smile": "CC1CC(=O)C2=C(O1)C(=C(C(C2=O)(C)CC=C(C)CCC=C(C)C)O)C","Ingredient_weight": "358.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10809","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "5318374","DrugBank_id": "NA"}
4-hydtoxy-2,6,8-trimethyl-6-(3,7-dimethyl-2,6-octadienyl)-2h-1-benzopyran-5,7(3h,6h)-dione
{"Ingredient_id": "HBIN010580","Ingredient_name": "4-hydtoxy-2,6,8-trimethyl-6-(3,7-dimethyl-2,6-octadienyl)-2h-1-benzopyran-5,7(3h,6h)-dione","Alias": "NA","Ingredient_formula": "C22H30O4","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "31283","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
5-hydroxy-2,6,8-trimethyl-8-(3,7-dimethyl-2,6-octadienyl)-2h-1-benzopyran-4,7(3h,8h)-dione
{"Ingredient_id": "HBIN011587","Ingredient_name": "5-hydroxy-2,6,8-trimethyl-8-(3,7-dimethyl-2,6-octadienyl)-2h-1-benzopyran-4,7(3h,8h)-dione","Alias": "NA","Ingredient_formula": "C22H30O4","Ingredient_Smile": "CC1CC(=O)C2=C(O1)C(C(=O)C(=C2O)C)(C)CC=C(C)CCC=C(C)C","Ingredient_weight": "358.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10810","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "5318375","DrugBank_id": "NA"}
5-hydroxy-2,8,6-trimethyl-8-(3,7-dimethyl-2,6-octadienyl)-2h-1-betzopyran-4,7(3h,8h)-dione
{"Ingredient_id": "HBIN011588","Ingredient_name": "5-hydroxy-2,8,6-trimethyl-8-(3,7-dimethyl-2,6-octadienyl)-2h-1-betzopyran-4,7(3h,8h)-dione","Alias": "NA","Ingredient_formula": "C22H30O4","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "31284","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}